HomeBIOVF • OTCMKTS
add
Swedish Orphan Biovitrum AB (publ)
Nakaraang pagsara
$28.30
Sakop ng taon
$22.87 - $32.25
Market cap
117.48B SEK
Average na Volume
59.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 6.89B | 33.40% |
Gastos sa pagpapatakbo | 3.52B | 4.14% |
Net na kita | 1.46B | 1,457.45% |
Net profit margin | 21.24 | 1,067.03% |
Kita sa bawat share | 4.31 | 713.21% |
EBITDA | 3.00B | 89.53% |
Aktuwal na % ng binabayarang buwis | 14.49% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 594.00M | -12.39% |
Kabuuang asset | 72.20B | -4.47% |
Kabuuang sagutin | 35.09B | -14.71% |
Kabuuang equity | 37.11B | — |
Natitirang share | 343.44M | — |
Presyo para makapag-book | 0.26 | — |
Return on assets | 7.15% | — |
Return on capital | 9.59% | — |
Cash Flow
Net change in cash
| (SEK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.46B | 1,457.45% |
Cash mula sa mga operasyon | 1.20B | 13.52% |
Cash mula sa pag-invest | -2.20B | -431.88% |
Cash mula sa financing | 860.00M | 211.11% |
Net change in cash | -185.00M | -65.18% |
Malayang cash flow | -3.51B | -219.76% |
Tungkol
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Itinatag
1939
Website
Mga Empleyado
1,814
